|
MechanismProton pump inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date14 Feb 2023 |
The Efficacy and Safety of the Combination Therapy of Keverprazan Hydrochloride Tablets and Amoxicillin for Helicobacter pylori-positive Chronic Gastritis: A Prospective, Multicenter, Randomized Controlled Study
/ Not yet recruitingPhase 1IIT Keverprazan Hydrochloride Tablets dual therapy, quadruple therapy efficacy and safety of helicobacter pylori eradication: a multicenter, open label, randomized controlled study
/ Not yet recruitingPhase 4 Efficacy and safety of keverprazan in the treatment of non-erosive reflux disease:A randomized controlled trial
100 Clinical Results associated with Jiangsu Wanbang Pharmaceutical Marketing & Distribution Co. Lt
0 Patents (Medical) associated with Jiangsu Wanbang Pharmaceutical Marketing & Distribution Co. Lt
100 Deals associated with Jiangsu Wanbang Pharmaceutical Marketing & Distribution Co. Lt
100 Translational Medicine associated with Jiangsu Wanbang Pharmaceutical Marketing & Distribution Co. Lt